Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients.

Dear Editor,

Predicting recovery of renal function in patients with acute kidney injury (AKI) supported with renal replacement therapy (RRT) is one of the top ten questions in the field of current AKI research. However, defining renal recovery and accordingly the best time for discontinuation of RRT is difficult, as reliable biomarkers are lacking.

The Beginning and Ending Supportive Therapy for the Kidney (BEST Kidney) study identified urine production (>500 mL/24 h) as the best predictor for successful discontinuation of RRT [area under the curve (AUC) 0.81] in contrast to serum creatinine (SCr, AUC 0.64); however, its predictive value is severely confounded by the use of diuretics [1].

Neutrophil gelatinase-associated lipocalin (NGAL), a 25-kDa protein involved in iron transportation, is a potential tool for determination of initiation of RRT [2, 3]. However, once a patient is initiated on RRT, it remains to be elucidated how plasma NGAL concentrations will change.

To determine plasma NGAL clearance and sieving coefficient (SQ) during continuous RRT (CRRT), we measured prefilter and effluent NGAL concentrations in three subjects after informed consent was obtained. Patients were hemofiltered with zero fluid balance, 2 L postdilution mode in continuous veno-venous hemofiltration. Blood flow was set at 200 mL/min, and regional citrate anticoagulation was used. The filters were ethylene oxide (ETO)-sterilized Aquamax HF 19 with an in vitro cutoff point of 55 kDa.

NGAL levels were measured using a research-based enzyme-linked immunosorbent assay with detection limit of 10–4,000 ng/mL. NGAL clearance per minute was estimated using the assumed stable plasma concentrations during CRRT over the first 12 h and the calculated amount of NGAL present in the total effluent. SQ was calculated by dividing the NGAL effluent concentration by the NGAL prefilter plasma concentration.

Three male anuric patients were studied (age 40–64 years). Their admission diagnoses were hemorrhagic shock, cardiopulmonary resuscitation, and multitrauma. Baseline SCr values were 0.57, 0.66, and 0.68 mg/dL, with SCr at time of CRRT initiation of 3.7, 9.7, and 12.3 mg/dL. Estimated median (standard deviation, SD) plasma NGAL clearance was 4.8 (1.89) mL/min with median (SD) SQ of 0.147 (0.04). The prefilter and effluent NGAL concentrations are plotted against time in Fig. 1.

Fig. 1

Temporal patterns of the prefilter plasma and effluent NGAL concentrations (ng/ml) in hours after initiation of continuous veno-venous renal replacement therapy in three individuals with anuric AKI

Normally, plasma NGAL is cleared through glomerular filtration and entirely processed by proximal tubular cells [4]. However, in case of AKI, plasma concentrations rise quickly, even when estimated glomerular filtration rate (eGFR) is still normal, and tend to decrease quickly when the injurious event subsides [5]. Therefore, NGAL might have potential to be an early indicator of renal recovery in critically ill patients supported by RRT.

Our results suggest that plasma NGAL is hardly cleared during continuous veno-venous hemofiltration. A possible explanation lies in the fact that larger serum proteins effectively lower the passage of small proteins by forming a gel layer over the membrane pores.

In conclusion, we have shown that CRRT does not substantially influence plasma NGAL concentration and therefore does not need to be taken into account when kinetics of plasma NGAL levels are used as an indicator for persistent renal injury or renal recovery in hemofiltered critically ill patients.